First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. (Record no. 30021102)

MARC details
000 -LEADER
fixed length control field 00913 a2200229 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518054545.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2234-943X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3389/fonc.2019.00701
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Viscuse, Paul V
245 00 - TITLE STATEMENT
Title First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Frontiers in oncology
Date of publication, distribution, etc. 2019
300 ## - PHYSICAL DESCRIPTION
Extent 701 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Price, Katharine A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garcia, Joaquin J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schembri-Wismayer, David J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chintakuntlawar, Ashish V
773 0# - HOST ITEM ENTRY
Title Frontiers in oncology
Related parts vol. 9
-- p. 701
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3389/fonc.2019.00701">https://doi.org/10.3389/fonc.2019.00701</a>
Public note Available from publisher's website

No items available.